ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/02 | 1,013 | 1,023 | 1,002 | 1,013 | -4 | -0.4% | 122,500 |
2023/02/01 | 1,005 | 1,033 | 1,003 | 1,017 | +1 | +0.1% | 97,400 |
2023/01/31 | 1,000 | 1,025 | 999 | 1,016 | +9 | +0.9% | 167,000 |
2023/01/30 | 1,033 | 1,040 | 1,006 | 1,007 | -33 | -3.2% | 249,000 |
2023/01/27 | 1,052 | 1,052 | 1,026 | 1,040 | -12 | -1.1% | 280,600 |
2023/01/26 | 1,041 | 1,060 | 1,034 | 1,052 | +11 | +1.1% | 272,800 |
2023/01/25 | 1,031 | 1,053 | 1,020 | 1,041 | -7 | -0.7% | 226,900 |
2023/01/24 | 1,078 | 1,081 | 1,045 | 1,048 | -37 | -3.4% | 425,100 |
2023/01/23 | 1,076 | 1,111 | 1,060 | 1,085 | +2 | +0.2% | 598,400 |
2023/01/20 | 1,131 | 1,132 | 1,074 | 1,083 | -105 | -8.8% | 1,015,500 |
2023/01/19 | 1,158 | 1,213 | 1,122 | 1,188 | +82 | +7.4% | 2,303,300 |
2023/01/18 | 1,094 | 1,114 | 1,077 | 1,106 | +32 | +3% | 172,800 |
2023/01/17 | 1,119 | 1,119 | 1,074 | 1,074 | -33 | -3% | 250,900 |
2023/01/16 | 1,134 | 1,152 | 1,107 | 1,107 | -57 | -4.9% | 212,500 |
2023/01/13 | 1,182 | 1,183 | 1,161 | 1,164 | -21 | -1.8% | 96,300 |
2023/01/12 | 1,191 | 1,195 | 1,178 | 1,185 | -10 | -0.8% | 60,500 |
2023/01/11 | 1,181 | 1,214 | 1,180 | 1,195 | +39 | +3.4% | 166,700 |
2023/01/10 | 1,199 | 1,209 | 1,151 | 1,156 | -48 | -4% | 175,300 |
2023/01/06 | 1,169 | 1,209 | 1,169 | 1,204 | +19 | +1.6% | 147,400 |
2023/01/05 | 1,211 | 1,217 | 1,175 | 1,185 | +8 | +0.7% | 163,200 |
2023/01/04 | 1,234 | 1,239 | 1,177 | 1,177 | -55 | -4.5% | 176,700 |
2022/12/30 | 1,222 | 1,246 | 1,208 | 1,232 | +19 | +1.6% | 141,700 |
2022/12/29 | 1,185 | 1,224 | 1,185 | 1,213 | +16 | +1.3% | 99,700 |
2022/12/28 | 1,190 | 1,222 | 1,168 | 1,197 | -9 | -0.7% | 218,200 |
2022/12/27 | 1,220 | 1,235 | 1,203 | 1,206 | +8 | +0.7% | 142,000 |
2022/12/26 | 1,222 | 1,222 | 1,197 | 1,198 | -16 | -1.3% | 112,100 |
2022/12/23 | 1,200 | 1,222 | 1,194 | 1,214 | +7 | +0.6% | 173,500 |
2022/12/22 | 1,250 | 1,250 | 1,206 | 1,207 | -43 | -3.4% | 247,000 |
2022/12/21 | 1,250 | 1,265 | 1,235 | 1,250 | +15 | +1.2% | 148,000 |
2022/12/20 | 1,300 | 1,300 | 1,220 | 1,235 | -61 | -4.7% | 401,500 |
2022/12/19 | 1,332 | 1,336 | 1,288 | 1,296 | -39 | -2.9% | 231,600 |
2022/12/16 | 1,359 | 1,364 | 1,333 | 1,335 | -32 | -2.3% | 189,300 |
2022/12/15 | 1,357 | 1,374 | 1,342 | 1,367 | +9 | +0.7% | 137,700 |
2022/12/14 | 1,399 | 1,414 | 1,358 | 1,358 | -39 | -2.8% | 261,900 |
2022/12/13 | 1,417 | 1,421 | 1,385 | 1,397 | +4 | +0.3% | 236,700 |
2022/12/12 | 1,375 | 1,414 | 1,371 | 1,393 | +6 | +0.4% | 210,100 |
2022/12/09 | 1,354 | 1,396 | 1,339 | 1,387 | +41 | +3% | 254,500 |
2022/12/08 | 1,359 | 1,359 | 1,334 | 1,346 | -9 | -0.7% | 116,800 |
2022/12/07 | 1,327 | 1,355 | 1,312 | 1,355 | +18 | +1.3% | 247,700 |
2022/12/06 | 1,339 | 1,350 | 1,333 | 1,337 | -2 | -0.1% | 143,200 |
2022/12/05 | 1,340 | 1,360 | 1,324 | 1,339 | -4 | -0.3% | 205,900 |
2022/12/02 | 1,338 | 1,355 | 1,319 | 1,343 | +3 | +0.2% | 139,600 |
2022/12/01 | 1,355 | 1,364 | 1,329 | 1,340 | -6 | -0.4% | 175,800 |
2022/11/30 | 1,365 | 1,367 | 1,334 | 1,346 | -30 | -2.2% | 237,500 |
2022/11/29 | 1,353 | 1,390 | 1,340 | 1,376 | +33 | +2.5% | 317,300 |
2022/11/28 | 1,326 | 1,362 | 1,319 | 1,343 | +7 | +0.5% | 206,300 |
2022/11/25 | 1,331 | 1,347 | 1,312 | 1,336 | -3 | -0.2% | 226,600 |
2022/11/24 | 1,331 | 1,346 | 1,325 | 1,339 | +1 | +0.1% | 186,700 |
2022/11/22 | 1,319 | 1,358 | 1,309 | 1,338 | +28 | +2.1% | 305,700 |
2022/11/21 | 1,340 | 1,342 | 1,290 | 1,310 | -75 | -5.4% | 761,500 |
551~
600
件表示中 / 3374件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 41,800円 | +25.1% | - | 0.00% | - | 1.84倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
メディシノバ | 21,700円 | - | - | - | - | - |
|
- |
坪田ラボ | 41,100円 | +100.6% | - | 0.00% | 52.69倍 | 7.46倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
NANO | 13,300円 | -20.0% | - | 0.00% | - | 3.09倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
カイオム | 13,400円 | +92.3% | - | 0.00% | - | 4.75倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
市場注目の銘柄
チャート関連のコラム